Retrophin Announces Corporate Name Change to Travere Therapeutics, Inc.
SAN DIEGO, November 16, 2020 – Retrophin Inc., (NASDAQ: RTRX) today announced that the company has changed its global corporate name to Travere Therapeutics, Inc. Read the press release >